Drug Trial Radar · NCT01573923
Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis
Last checked: Nov 19, 2026Latest source record: Apr 14, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
320
Planned (sponsor's estimate)
Start
Jul 2014
Primary completion
Jul 2015
Study completion Oct 2015
Sponsor
- Lead sponsor
- Alliancells Bioscience Corporation LimitedIndustry
- Sponsor type
- Industry
- First posted
- Apr 10, 2012
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Liver cirrhosis and subsequent liver failure are leading causes of morbidity and mortality worldwide. Alcohol abuse and viral hepatitis are the most common causes of cirrhosis. Novel therapies are necessary to prevent or block the process of the disease. In this current prospective cohort, the investigators plan to organize four hospitals to determine the safety and efficacy of intravenous administration of umbilical mesenchymal stem cells in the treatment of patients with liver cirrhosis in next three years.
Conditions
- Liver Cirrhosis
Interventions
mesenchymal stem cellsBiological
Conventional therapy plus UC-MSC intravenous administration (4x107/40ml, once per three months, four times in one year)
Conventional therapyBiological
Conventional therapy without cell therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- survival timeTime frame: 3-year follow up
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
The 302 Hospital of Chinese People's Liberation Army
Beijing, Beijing Municipality, China · Recruiting
the First Affiliated Hospital of Lanzhou University
Lanzhou, Gansu, China · Recruiting
Hainan BOAO Life infinity international anti-aging medical center
Qionghai, Hainan, China · Recruiting
The first people's hospital of Lianyungang
Lianyungang, Jiangsu, China · Recruiting
Tongji Hospital of Tongji University
Shanghai, Shanghai Municipality, China · Recruiting
The 323 Hospital of Chinese People's Liberation Army
Xi’an, Shanxi, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.